Elevance Health, Inc.
ELV · XNYSCIK 1156039fmd_0CN2HRZRA2QM1T3717EZ4F9XR1Finance, Insurance and Real Estate · Hospital & Medical Service PlansTemplate: Insurance
Coverage: Jan 01, 2007 to Sep 30, 2026, 75 periods
Latest annual · FY2025
Millions- Total revenues
- 199,125
- Gross profit
- 177,947
- Operating income
- 7,199
- Net income
- 5,662
- Free cash flow
- 3,174
Latest quarter · Q3 FY2026
Millions- Total revenues
- 51,429
- Gross profit
- 45,789
- Operating income
- 1,269
- Net income
- 1,365
- Free cash flow
- 1,000
Daily close · ELVIEX trades only
Nov 13, 2025 to Nov 11, 2026 · 250 sessions429.67 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- +8.3%
- Revenue, 5 yearsFY2020 to FY2025
- +10.3%
- Net income, 5 yearsFY2020 to FY2025
- +4.4%
Elevance Health, Inc. (ELV) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $199.1 billion | $177 billion | +12.5% | 10-K 2026-02-06 · proof |
| Gross profit | $177.9 billion | $157.3 billion | +13.2% | 10-K 2026-02-06 · proof |
| Operating income | $7.2 billion | $7.9 billion | -8.4% | 10-K 2026-02-06 · proof |
| Net income | $5.7 billion | $6 billion | -5.3% | 10-K 2026-02-06 · proof |
| Cash from operating activities | $4.3 billion | $5.8 billion | -26.1% | 10-K 2026-02-06 · proof |
| Free cash flow | $3.2 billion | $4.6 billion | -30.3% | 10-K 2026-02-06 · proof |
| Total assets | $121.5 billion | $116.9 billion | +3.9% | 10-K 2026-02-06 · proof |
| Total liabilities | $77.5 billion | $75.5 billion | +2.7% | 10-K 2026-02-06 · proof |
| Cash and cash equivalents | $9.5 billion | $8.3 billion | +14.5% | 10-K 2026-02-06 · proof |
| Total debt | $32 billion | $31.2 billion | +2.6% | 10-K 2026-02-06 · proof |
- What was Elevance Health, Inc. (ELV)'s revenue in fiscal 2025?
- Elevance Health, Inc. (ELV) reported revenue of $199.1 billion for fiscal 2025 (the year ended Dec 31, 2025), against $177 billion the year before (+12.5%). Source: the 10-K filed with the SEC on Feb 6, 2026. SEC
- What was Elevance Health, Inc. (ELV)'s gross profit in fiscal 2025?
- Elevance Health, Inc. (ELV) reported gross profit of $177.9 billion for fiscal 2025 (the year ended Dec 31, 2025), against $157.3 billion the year before (+13.2%). Source: the 10-K filed with the SEC on Feb 6, 2026. SEC
- What was Elevance Health, Inc. (ELV)'s operating income in fiscal 2025?
- Elevance Health, Inc. (ELV) reported operating income of $7.2 billion for fiscal 2025 (the year ended Dec 31, 2025), against $7.9 billion the year before (-8.4%). Source: the 10-K filed with the SEC on Feb 6, 2026. SEC
- What was Elevance Health, Inc. (ELV)'s net income in fiscal 2025?
- Elevance Health, Inc. (ELV) reported net income of $5.7 billion for fiscal 2025 (the year ended Dec 31, 2025), against $6 billion the year before (-5.3%). Source: the 10-K filed with the SEC on Feb 6, 2026. SEC
- What was Elevance Health, Inc. (ELV)'s cash from operating activities in fiscal 2025?
- Elevance Health, Inc. (ELV) reported cash from operating activities of $4.3 billion for fiscal 2025 (the year ended Dec 31, 2025), against $5.8 billion the year before (-26.1%). Source: the 10-K filed with the SEC on Feb 6, 2026. SEC
- What was Elevance Health, Inc. (ELV)'s free cash flow in fiscal 2025?
- Elevance Health, Inc. (ELV) reported free cash flow of $3.2 billion for fiscal 2025 (the year ended Dec 31, 2025), against $4.6 billion the year before (-30.3%). Source: the 10-K filed with the SEC on Feb 6, 2026. SEC
- What are Elevance Health, Inc. (ELV)'s total assets?
- As of Dec 31, 2025, Elevance Health, Inc. (ELV) reported total assets of $121.5 billion, against $116.9 billion a year earlier (+3.9%). Source: the 10-K filed with the SEC on Feb 6, 2026. SEC
- What are Elevance Health, Inc. (ELV)'s total liabilities?
- As of Dec 31, 2025, Elevance Health, Inc. (ELV) reported total liabilities of $77.5 billion, against $75.5 billion a year earlier (+2.7%). Source: the 10-K filed with the SEC on Feb 6, 2026. SEC
- What are Elevance Health, Inc. (ELV)'s cash and cash equivalents?
- As of Dec 31, 2025, Elevance Health, Inc. (ELV) reported cash and cash equivalents of $9.5 billion, against $8.3 billion a year earlier (+14.5%). Source: the 10-K filed with the SEC on Feb 6, 2026. SEC
- What is Elevance Health, Inc. (ELV)'s total debt?
- As of Dec 31, 2025, Elevance Health, Inc. (ELV) reported total debt of $32 billion, against $31.2 billion a year earlier (+2.6%). Source: the 10-K filed with the SEC on Feb 6, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:ELV&period_type=annual&limit=5"Information only, not investment advice.